Science Explorer Back to mapMap

Most cited papers from Codex Biosolutions (United States)

Codex Biosolutions (United States)

What are the most cited papers from Codex Biosolutions (United States)?

The most cited paper from Codex Biosolutions (United States) is "Structural impact on SARS-CoV-2 spike protein by D614G substitution" (Jun Zhang, Yongfei Cai, Tianshu Xiao et al., 2021), with 477 citations. Next come "Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant" (310) and "Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants" (253).

Showing 35 of 35 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Structural impact on SARS-CoV-2 spike protein by D614G substitution Jun Zhang, Yongfei Cai, Tianshu Xiao et al. · Science Open access 16 Mar 2021 477
2 Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant Jun Zhang, Tianshu Xiao, Yongfei Cai et al. · Science Open access 26 Oct 2021 310
3 Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants Yongfei Cai, Jun Zhang, Tianshu Xiao et al. · Science Open access 24 Jun 2021 253
4 Structural basis of coreceptor recognition by HIV-1 envelope spike Md Munan Shaik, Hanqin Peng, Jianming Lü et al. · Nature 11 Dec 2018 234
5 Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification Jean B. Regard, Deepti Malhotra, Jelena Gvozdenovic‐Jeremic et al. · Nature Medicine Open access 29 Sep 2013 231
6 Structural and functional impact by SARS-CoV-2 Omicron spike mutations Jun Zhang, Yongfei Cai, Christy L. Lavine et al. · Cell Reports Open access Apr 2022 170
7 A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent Tianshu Xiao, Jianming Lü, Jun Zhang et al. · Nature Structural & Molecular Biology Open access 11 Jan 2021 154
8 Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein Jia Chen, James M. Kovacs, Hanqin Peng et al. · Science Open access 26 Jun 2015 139
9 Cryo-EM structure of SARS-CoV-2 postfusion spike in membrane Wei Shi, Yongfei Cai, Haisun Zhu et al. · Nature Open access 7 Jun 2023 118
10 Application of a homogenous membrane potential assay to assess mitochondrial function Srilatha Sakamuru, Xiao Li, Matias Sebastian Attene‐Ramos et al. · Physiological Genomics Open access 22 Mar 2012 97
11 Targeting TIGIT for Immunotherapy of Cancer: Update on Clinical Development Anand Rotte, Srikumar Sahasranaman, Nageshwar R. Budha · Biomedicines Open access 21 Sep 2021 74
12 Dose fractionation of CAR-T cells. A systematic review of clinical outcomes Matthew J. Frigault, Anand Rotte, Ayub Ansari et al. · Journal of Experimental & Clinical Cancer Research ReviewOpen access 10 Jan 2023 47
13 Chimeric Antigen Receptors Incorporating D Domains Targeting CD123 Direct Potent Mono- and Bi-specific Antitumor Activity of T Cells Haiying Qin, Justin P. Edwards, Liubov Zaritskaya et al. · Molecular Therapy Open access 16 Apr 2019 46
14 mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants Yunkai Yu, Dominic Esposito, Zhigang Kang et al. · Scientific Reports Open access 16 Feb 2022 44
15 Structural and functional characteristics of the SARS-CoV-2 Omicron subvariant BA.2 spike protein Jun Zhang et al. · Nature Structural & Molecular Biology Jul 2023 32
16 Antigenicity-defined conformations of an extremely neutralization-resistant HIV-1 envelope spike Yongfei Cai, Selen Karaca-Griffin, Jia Chen et al. · Proceedings of the National Academy of Sciences Open access 10 Apr 2017 22
17 Structural Characterization and Modeling of a Respiratory Syncytial Virus Fusion Glycoprotein Nanoparticle Vaccine in Solution Susan Krueger, Joseph E. Curtis, Daniel R. Scott et al. · Molecular Pharmaceutics Open access 16 Dec 2020 16
18 A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of ThymoQuinone Formula (TQF) for Treating Outpatient SARS-CoV-2 Hassan Bencheqroun et al. · Pathogens Open access 7 May 2022 12
19 A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent in vitro Tianshu Xiao, Jianming Lü, Jun Zhang et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 18 Sep 2020 12
20 Antibody‐mediated SARS‐CoV‐2 entry in cultured cells Md. Golam Kibria, Christy L. Lavine, Weichun Tang et al. · EMBO Reports Open access 2 Nov 2023 11
21 Non-invasive detection and complementary diagnosis of liver metastases via chemokine receptor 4 imaging Hua Yang, Shanshan Tan, Jingjuan Qiao et al. · Cancer Gene Therapy Open access 10 Feb 2022 10
22 Unique Aggregation of Retroviral Particles Pseudotyped with the Delta Variant SARS-CoV-2 Spike Protein Jennifer D. Petersen, Jianming Lu, Wendy Fitzgerald et al. · Viruses Open access 11 May 2022 7
23 Potential functional food ingredients: Insufficient ingredient descriptions Steven M. Gendel · Journal of Functional Foods Open access 31 Aug 2021 6
24 Structural and functional characteristics of SARS-CoV-2 Omicron subvariant BA.2 spike Jun Zhang et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 28 Apr 2022 5
25 Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infection Abdelrahim Maen, Betül Gök Yavuz, Yehia Ibrahim Mohamed et al. · Frontiers in Pharmacology Open access 6 Feb 2024 4
26 Phosphodiesterase 2 and Its Isoform A as Therapeutic Targets in the Central Nervous System Disorders Sanjay Kisan Metkar, Yuqing Yan, Yue Lu et al. · CNS & Neurological Disorders - Drug Targets 15 Oct 2023 4
27 Distinct in vitro and in vivo neutralization profiles of monoclonal antibodies elicited by the receptor binding domain of the ancestral SARS‐CoV‐2 Hyung J. Kwon et al. · Journal of Medical Virology Open access Mar 2023 3
28 Antibody-mediated cell entry of SARS-CoV-2 Md. Golam Kibria, Christy L. Lavine, Weichun Tang et al. · bioRxiv (Cold Spring Harbor Laboratory) Preprint 20 Feb 2023 2
29 Estimation of Human Emotion Using Total-Hemoglobin Data Measured by A Lightweight fNIRS Device Daisuke Fukui, Takushige Katsura, Masashi Egi et al. · IEEJ Transactions on Electronics Information and Systems 31 May 2021 2
30 620O CART-ddBCMA for multiple myeloma: Interim results from phase I study M. Frigault, Jacalyn M. Rosenblatt, Noopur S Raje et al. · Annals of Oncology Open access Sep 2022 1
31 Food fraud mitigation: strategic approaches and tools Karen Everstine, Bert Pöpping, Steven M. Gendel · Elsevier eBooks Book chapter 2021 1
32 Long-term physical and mental health effects of unresolved disaster-related bereavement: evidence from an 8-year propensity score–matched cohort study Eun-Joo Park, Jiwon Han, Maenseok Noh et al. · European Journal of Psychotraumatology Open access 24 Mar 2026 0
33 TMOD-30. Microglia and macrophages at the brain-tumor border have enriched expression of interferon gamma and complement signaling in naturally occurring canine brain metastatic melanoma: insight into the mechanism(s) of melanoma brain metastasis from man’s best friend Kulani Simafranca-Narte, Clifford G. Tepper, Ryan G. Toedebusch et al. · Neuro-Oncology Open access Nov 2025 0
34 The Delta variant SARS-CoV-2 spike protein uniquely promotes aggregation of pseudotyped viral particles Jennifer D. Petersen, Jianming Lu, Wendy Fitzgerald et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 8 Apr 2022 0
35 Proposal of Model-based HMI Development Method for In-vehicle System Yoshitaka Atarashi, Manabu Morita, Norihisa Komoda · IEEJ Transactions on Electronics Information and Systems Open access 31 Oct 2018 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.